MHC transmission: Insights into gender bias in MS susceptibility

Neurology

Volumn 76, Issue 3, 2011, Pages 242-246

  Chao, M J ^a   Ramagopalan, S V ^a   Herrera, B M ^a   Orton, S M ^a   Handunnetthi, L ^a   Lincoln, M R ^a   Dyment, D A ^a   Sadovnick, A D ^b   Ebers, G C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ADULT; ARTICLE; CONSENSUS; CONTROLLED STUDY; FAMILY; FEMALE; GENDER BIAS; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC DISTANCE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; SEX RATIO;

EID: 78751621966     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318207b060     Document Type: Article

References (33)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshen-ker BG. Multiple sclerosis. N Engl J Med 2000;343:938-952.
2. Chao MJ, Barnardo MC, Lincoln MR, et al. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci USA 2008;105:13069-13074.
3. Lincoln MR, Montpetit A, Cader MZ, et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005; 37:1108-1112.
4. Dyment DA, Herrera BM, Cader MZ, et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 2005;14: 2019-2026.
5. Ramagopalan SV, Morris AP, Dyment DA, et al. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet 2007;3:1607-1613.
6. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neu-rol 2006;5:932-936.
7. Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci USA 2003;100: 12877-12882.
8. Ebers GC, Sadovnick AD, Dyment DA, Yee IM, Willer CJ, Risch N. Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 2004;363:1773-1774.
9. Sadovnick AD, Bulman D, Ebers GC. Parent-child concordance in multiple sclerosis. Ann Neurol 1991;29:252-255.
10. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol 2008;7:268-277.
11. Sadovnick AD, Risch NJ, Ebers GC. Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method: Canadian Collaborative Study Group. Can J Neurol Sci 1998;25:216-221.
12. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998;63:259-266.
13. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003;25:115-121.
14. Sadovnick AD, Baird PA, Ward RH. Multiple sclerosis: updated risks for relatives. Am J Med Genet 1988;29:533-541.
15. Ebers GC, Yee IM, Sadovnick AD, Duquette P. Conjugal multiple sclerosis: population-based prevalence and recurrence risks in offspring: Canadian Collaborative Study Group. Ann Neurol 2000;48:927-931.
16. Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis: Canadian Collaborative Study Group. Nature 1995;377:150-151.
17. Brain WR. Critical review: disseminated sclerosis. Q J Med 1930;23:343-391.
18. Murray S, Bashir K, Penrice G, Womersley SJ. Epidemiology of multiple sclerosis in Glasgow. Scott Med J 2004;49: 100-104.
19. Dyment DA, Cader MZ, Willer CJ, Risch N, Sadovnick AD, Ebers GC. A multigenerational family with multiple sclerosis. Brain 2002;125:1474-1482.
20. Chao MJ, Ramagopalan SV, Herrera BM, et al. Epigenet-ics in multiple sclerosis susceptibility: difference in trans-generational risk localizes to the major histocompatibility complex. Hum Mol Genet 2009;18:261-266.
21. Ramagopalan SV, Herrera BM, Bell JT, et al. Parental transmission of HLA-DRB1*15 in multiple sclerosis. Hum Genet 2008;122:661-663.
22. Ramagopalan SV, Link J, Byrnes JK, et al. HLA-DRB1 and month of birth in multiple sclerosis. Neurology 2009; 73:2107-2111.
23. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009;5:e1000369.
24. Fernando MM, Stevens CR, Walsh EC, et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 2008;4:e1000024.
25. Beeson PB. Age and sex associations of 40 autoimmune diseases. Am J Med 1994;96:457-462.
26. Foster H, Kelly C, Griffiths I. Sex ratios in HLA related autoimmune disease. Ann Rheum Dis 1991;50:969.
27. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001;2:777-780.
28. Strickland FM, Richardson BC. Epigenetics in human au-toimmunity: epigenetics in autoimmunity: DNA methyl-ation in systemic lupus erythematosus and beyond. Autoimmunity 2008;41:278-286.
29. Kerkel K, Spadola A, Yuan E, et al. Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet 2008;40:904-908.
30. Schalkwyk LC, Meaburn EL, Smith R, et al. Allelic skewing of DNA methylation is widespread across the genome. Am J Hum Genet 2010;86:196-212.
31. Hellman A, Chess A. Extensive sequence-influenced DNA methylation polymorphism in the human genome. Epige-netics Chromatin 2010;3:11.
32. Horton R, Wilming L, Rand V, et al. Gene map of the extended human MHC. Nat Rev Genet 2004;5:889-899.
33. Zingg JM, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 1997;18:869-882.